Transplantation in the patient with hepatitis C

Journal of the American Society of Nephrology

Volumn 11, Issue 7, 2000, Pages 1343-1353

  Morales, José M ^a   Campistol, Josep M ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIGEN; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

ARTICLE; CHOLESTATIC HEPATITIS; DISEASE COURSE; DISEASE TRANSMISSION; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY;

EID: 0034044647     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1171343     Document Type: Article

References (91)

1. Rodicio JL, Morales JM: Liver disease in renal transplant patients. In: Textbook of Nephrology, Vol. 2, edited by Massry SG, Glassock RJ, Baltimore, Williams & Wilkins, 1995, pp 1684-1689
2. Pereira BJG: Hepatitis C in organ transplantation: Its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens 2: 912-922, 1993
3. De Francesco R: Molecular virology of the hepatitis C virus. J Hepatol 31[Suppl 1]: 47-53, 1999
4. Simmonds P: Viral heterogenity of hepatitis C virus. J Hepatol 31[Suppl 1]: 54-60, 1999
5. Mondelli MU, Silini E: Clinical significance of hepatitis C virus genotypes. J Hepatol 31[Suppl 1]: 65-70, 1999
6. Naoumov NV: Hepatitis C virus infection in Eastern Europe. J Hepatol 31[Suppl 1]: 84-87, 1999
7. Thomas DL: Hepatitis C epidemiology. Curr Top Microbiol Immunol 242: 25-41, 2000
8. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M: Hepatitis C virus antibodies among risk groups in Spain. Lancet 11: 294-297, 1989
9. Pawlotsky JM: Diagnosis tests for hepatitis C. J Hepatol 31[Suppl 1]: 71-79, 1999
10. Hoofnagle JH: Hepatitis C: The clinical spectrum of disease. Hepatology 26[Suppl 1]: 15S-20S, 1997
11. Ferrari C, Urban S, Penna A, Cavalli A, Valli A, Lamonaca V, Bertoni R, Boni C, Barbieri K, Uggeri J, Fiaccadori F: Immunopathogenesis of hepatitis C virus infection. J Hepatol 31[Suppl 1]: 31-38, 1999
12. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P, Musset L, Veyssier P, Raguin G, Piette JC: Extrahepatic manifestations associated with hepatitis C virus infection: A prospective multicenter study of 321 patients. The GERMIVIC. Medicine (Baltimore) 79: 47-56, 2000
13. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465-470, 1993
14. Hoofnagle JH, Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336: 347-356, 1997
15. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. The Hepatitis Interventional Therapy Group. N Engl J Med 339: 1485-1492, 1998
16. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J: Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. The International Hepatitis Interventional Therapy Group. Lancet 352: 1426-1432, 1998
17. Chan TM, Lok ASF, Cheng IKP, Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 17: 5-8, 1993
18. Fabrizi F, Lunghi G, Guarniori I, Raffaele L, Crepaldi M, Pagano A, Locatelli F: Incidence of seroconversion for hepatitis C virus in chronic hemodialysis patients: A prospective study. Nephrol Dial Transplant 9: 1611-1615, 1994
19. Barril G: Transmisión de la hepatitis por virus C en las unidades de diálisis. Nefrología 18[Suppl 1]: 46-52, 1998
20. Blumberg A, Zehnder C, Burckhard JJ: Prevention of hepatitis C in hemodialysis units: A prospective study. Nephrol Dial Transplant 10: 230-233, 1995
21. Pereira BJ, Levey AS: Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 51: 981-999, 1997
22. De Medina M, Hill M, Sullivan HO, Leclerq B, Pennell JP, Jeffers L, Reddy KR, Schiff ER, Perez GO: Detection of antihepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: Correlation with hepatitis C virus RNA. J Lab Clin Med 132: 73-75, 1998
23. Caramelo C, Bartolome J, Albalate M, de Sequera P, Navas S, Bermejillo T, Oliva H, Marriott E, Ortiz A, Ruiz Tunon C, Casado S, Carreno V: Undiagnosed hepatitis C virus infection in hemodialysis patients: Value of HCV RNA and liver enzyme levels. Kidney Int 50: 2027-2031, 1996
24. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF: Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 94: 159-163, 1999
25. Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis J: The impact of renal transplantation on survival in hepatitis C positive end-stage renal disease patients. Am J Kidney Dis 29: 608-614, 1997
26. Pereira BJG, Wright TL, Schmid CH, Levey AS: The impact of pretransplantation hepatitis C infection on the outcome of renal transplantations. Transplantation 60: 799-805, 1995
27. Legendre CH, Garrigue V, Le Bihan C, Mamzer-Bruneel MF, Chaix ML, Landais P, Kreis H, Pol S: Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 65: 667-670, 1998
28. Roth D, Zucker K, Cirocco, De Mattos A, Burke GW, Nery J, Esquenazi V, Babischkin S, Miller J: The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 45: 238-244, 1994
29. Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Bréchet CH: Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 47: 1412-1418, 1995
30. Campistol JM, Esforzado N, Martinez J, Rosello L, Veciana L, Modol J, Casellas J, Pons M, de Las Cuevas X, Piera J, Oliva JA, Costa J, Barrera JM, Bruguera M: Efficacy and tolerance of interferon-α(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients: Pre- and post-renal transplantation assessment. Nephrol Dial Transplant 14: 2704-2709, 1999
31. Rostaing L, Chatelut E, Payen JL, Izopet J, Thalamas C, Ton-That H, Pascal JP, Durand D, Canal P: Pharmacokinetics of αIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications. J Am Soc Nephrol 9: 2344-2348, 1998
32. Morales JM: Renal transplantation in patients positive for hepatitis B or C (Pro). Transplant Proc 30: 2064-2069, 1998
33. Vosnides GG: Hepatitis C in renal transplantation. Nephrology Forum. Kidney Int 52: 843-861, 1997
34. Goffin E, Pirson Y, Cornu C, Geubel A, Squifflet JP, Van Ypersele de Strihou C: Outcome of HCV infection after renal transplantation. Kidney Int 45: 551-555, 1994
35. Morales JM, Campistol JM, Andres A, Rodicio JL: Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens 7: 177-183, 1998
36. Roth D, Zucker K, Cirocco R, Burke G, Ciancio C, Esquenazi V, Swanson SJ III, Miller J: A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 61: 886-889, 1996
37. Muñoz de Bustillo E, Ibarrola C, Colina F, Castellano G, Fuertes A, Andres A, Aguado JM, Rodicio JL, Morales JM: Fibrosing cholestatic hepatitis in hepatitis C virus-infected transplant recipients. J Am Soc Nephrol 9: 1109-1113, 1998
38. Ponz E, Campistol JM, Bruguera M, Barrera JM, Gil C, Pinto JB, Andreu J: Hepatitis C virus infection among kidney transplant recipients. Kidney Int 40: 748-751, 1991
39. Haem J, Berthoux P, Mosnier JF, Grattard F, Cecillon S, Pozzetto B, Alamartine E, Berthoux F: Clear evidence of the existence of healthy carriers of hepatitis C virus among renal transplant patients. Transplantation 62: 699-700, 1996
40. Rao KV, Anderson WR, Kasiske BL, Dahl DC: Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant patients. Am J Med 94: 241-250, 1993
41. Pol S, Legendre C, Saltiel C, Carnot F, Brechot C, Berthelot P, Mattinger B, Kreis H: Hepatitis C virus in kidney recipients, epidemiology and impact on renal transplantation. J Hepatol 15: 202-206, 1992
42. Glicklich D, Kapoian T: Should the hepatitis C positive end stage renal disease patient be transplanted? Semin Dial 9: 5-8, 1996
43. Jeng LB, Huang CC, Lai MK, Chu SH: Hepatocellular carcinoma after kidney transplantation. Transplant Proc 31: 1273-1274, 1999
44. Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, Williams R: Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13: 150-157, 1991
45. Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, Cosimi AB: Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation. Transplantation 66: 1254-1258, 1998
46. Pol S, Cavalcanti R, Carnot F, Legendre C, Driss F, Chaix ML, Thervet E, Chkoff N, Brechot C, Berthelot P, Kreis H: Azathioprine hepatitis in kidney transplant recipients: A predisposing role of chronic viral hepatitis. Transplantation 61: 1774-1776, 1996
47. Rao VK, Anderson WR, Kasiske BL, Dahl CJ: The safety and effectiveness of alpha interferon treatment on chronic viral hepatitis in kidney transplant recipients [Abstract]. J Am Soc Nephrol 4: 958, 1993
48. Harihara Y, Kurooka Y, Yanagisawa T, Kuzuhara K, Otsubo O, Kumada H: Interferon therapy in renal allograft recipients with chronic hepatitis C [Abstract]. Transplant Proc 26: 2075, 1994
49. Thervet E, Pol S, Legendre C, Gagnadoux M-F, Cavalcanti R, Kreis H: Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients: A pilot study. Transplantation 58: 625-628, 1994
50. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D: Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 59: 1426-1431, 1995
51. Magnone M, Holley JL, Shapiro R, Scantlebury V, McCauley J, Jordan M, Vivas C, Starzl T, Johnson JP: Interferon-alpha induced acute renal allograft rejection. Transplantation 59: 1068-1070, 1995
52. Ozgür O, Bayacioglu S, Telatar H, Haberal M: Recombinant alpha interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant 10: 2104-2106, 1995
53. Hanafusa T, Ichikawa Y, Hishikawa H, Kyo M, Fukunishi T, Kokado Y, Okuyama A, Shinji Y, Nagano S: Prospective study on the impact of hepatitis C infection on kidney transplant patients over 20 years. Transplantation 66: 471-476, 1998
54. Garnier JL, Chevallier P, Dubernard JM, Trepo C, Touraine JL, Chossegros P: Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients [Abstract]. Transplant Proc 29: 783, 1997
55. Smith JP: Treatment of chronic hepatitis with amantadine. Dig Dis Sci 42: 1681-1687, 1997
56. Johnson RJ, Wilson R, Yamabe H, Couser W, Alpers CE, Wener MH, Davis C, Gretch DR: Renal manifestations of hepatitis C virus infection. Kidney Int 46: 1255-1263, 1994
57. Roth D: Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 25: 3-16, 1995
58. Morales JM, Campistol JM, Andres A, Rodicio JL: Glomerular diseases in patients with hepatitis C virus infection after renal transplantation. Curr Opin Nephrol Hypertens 6: 511-515, 1997
59. Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M: Pretransplant hepatitis C virus infection: A predictor of proteinuria after renal transplantation. Transplantation 65: 741-744, 1998
60. Cruzado JM, Gil-Vernet S, Ercilla G, Seron D, Carrera M, Bas J, Torras J, Alsina J, Grinyo JM: Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. J Am Soc Nephrol 7: 2469-2475, 1996
61. Roth D, Cirocco R, Zucker K, Ruiz P, Viciana A, Burke G, Carreno M, Esquenazi V, Miller J: De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 59: 1676-1682, 1995
62. Hammoud H, Haem J, Laurent B, Alamartine E, Diab N, Defilippis JP, Berthoux P, Berthoux F: Glomerular disease during HCV infection in renal transplantation. Nephrol Dial Transplant 11[Suppl 4]: 54-55, 1996
63. Brunkhorst R, Kliem V, Koch KM: Recurrence of membrano-proliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C. Nephron 72: 456-467, 1996
64. Morales JM, Pascual J, Campistol JM, Fernandez-Zatarian G, Muñoz MA, Andres A, Praga M, Martinez MA, Usera G, Fuertes A, Oppenheimer F, Artal P, Darnell S, Rodicio JL: Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 63: 1634-1639, 1997
65. Baid S, Pascual M, Williams WW Jr, Tolkoff-Rubin N, Johnson SM, Collins B, Chung RT, Delmonico FL, Cosimi AB, Colvin RB: Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 10: 146-150, 1999
66. Otha S, Yokoyama H, Wada T, Skai N, Shimizu M, Katyo T, Furuichi K, Segawa C, Hisada Y, Kobasayi K: Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis 33: 1040-1048, 1999
67. Pham HP, Feray C, Samuel D, Gigou M, Azoulay D, Paradis V, Ducret F, Charpentier B, Debuire B, Lemoine A: Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int 54: 1311-1319, 1998
68. Rao KV, Ma J: Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 62: 1765-1769, 1996
69. Corell A, Morales JM, Mandroño A, Muñoz MA, Fuertes A, Arnaiz Villena A: Immunosuppression induced by hepatitis C virus infection reduces acute renal transplant rejection. Lancet 346: 1497-1498, 1995
70. Gentil MA, Rocha JL, Rodriguez-Algarra G, Pereira P, Lopez R, Bernai G, Muñoz J, Naranjo M, Mateos J: Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 14: 2455-2460, 1999
71. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, Thibault V, Cadranel JF, Bernard B, Opolon P, Coriat P, Bitker MO: Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29: 257-263, 1999
72. Aroldi A, Lampertico P, Elli A, Lunghi G, Tarantino A, Montagnino G, Colombo M, Ponticelli C: Long-term evolution of anti-HCV-positive renal transplant recipients. Transplant Proc 30: 2076-2078, 1998
73. Pereira BJG, Natov S, Bouthot BA, Murthy BVR, Ruthazer R, Schmid CH, Levey AS, for The New England Organ Bank Hepatitis C Study Group: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 53: 1374-1381, 1998
74. Pereira BJG, MiIford EL, Kirkman RL, Levey AS: Transmission of hepatitis C virus by organ transplantation N Engl J Med 325: 454-460, 1991
75. Pereira BJG, Milford EL, Kirkman RL: Prevalence of HCV-RNA in hepatitis C antibody-positive cadaver organ donors and their recipients. N Engl J Med 327: 910-915, 1992
76. Diethelm AG, Roth D, Ferguson RM, Schiff ER, Hardy MA, Starzl TE, Miller J, Van Thiel D, Najarian JS: Transmission of HCV by organ transplantation N Engl J Med 326: 410-411, 1992
77. Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, Olson L, Burke GW, Nery JR, Esquenazi V, Schiff ER, Miller J: Detection of hepatitis C infection among organ donors: Evidence for low transmission of disease. Ann Intern Med 117: 470-475, 1992
78. Tesi RJ, Waller K, Morgan CJ, Delaney S, Elkhammas EA, Henry ML, Fergusson RM: Transmission of hepatitis C by kidney transplantation: The risks. Transplantation 57: 826-831, 1994
79. Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C: Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation 55: 674-675, 1993
80. Aeder MI, Shield CF, Tegtmeier GE, Bayer W, Luger AM, Nelson PW, Pierce GE, Polito A, Wilber JC, Johnson P: The incidence and clinical impact of hepatitis C virus (HCV) positive donors in cadaveric transplantation. Transplant Proc 25: 1469-1471, 1993
81. Mendez R, EL-Shahawy M, Obispo E, Aswad S, Mendex RG: Four years follow-up of hepatitis C positive kidneys into hepatitis C negative recipients [Abstract]. Am J Soc Nephrol 6: 1105, 1995
82. Pereira BJG, Wright TL, Schmid CH, Levey AS, for The New England Organ Bank Hepatitis C Study Group: A controlled study of hepatitis C transmission by organ transplantation. Lancet 345: 484-487, 1995
83. Kiberd BC: Should hepatitis C-infected kidneys be transplanted in the United States? Transplantation 57: 1068-1072, 1994
84. Morales JM, Rodicio JL: Should hepatitis C-positive donors be accepted for renal transplantation? Curr Opin Nephrol Hypertens 5: 199-201, 1996
85. Morales JM, Andrés A, Campistol JM: Hepatitis C virus and organ transplantation. N Engl J Med 328: 511-512, 1993
86. Matesanz R, National Transplant Coordinator, Spain: Organización de Trasplantes, Memoria, 1993 (communication to all transplant centers in Spain)
87. Morales JM, Campistol JM, Castellano G, Andres A, Colina F, Fuertes A, Ercilla G, Bruguera M, Andreu J, Carretero P, Rodicio JL, Levey AS, Pereira BJG: Transplantation of kidneys from donors with hepatitis C antibody into recipients with pretransplantation anti-HCV. Kidney Int 47: 236-240, 1995
88. Ali MK, Light JA, Barhyte DY, Sasaki TM, Currier CB Jr, Grandas O, Fowlkes D: Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 66: 1694-1697, 1998
89. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I: Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 60: 642-647, 1995
90. Morales JM, Andres A, Campistol JM, Arriola M, Matamoros F, Cubas A, Fuertes A, Oppenheimer F, Rodicio JL, Pereira BJG: Transplantation of kidneys from donors with hepatitis C antibody into HCV RNA positive recipients: A good alternative to use these organs [Abstract]. Transplantation 65: 262, 1998
91. Dominguez-Gil B, Muñoz MA, Campistol JM, Andres A, Fuertes A, Oppenheimer F, Bruguera M, Castellano G, Rodicio JL, Pereira BJG, Morales JM: Ten years experience in transplantation of kidneys from HCV positive donors into HCV positive recipients [Abstract]. Transplantation 69: S404, 2000